{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:19:48Z","timestamp":1789193988946,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Alzheimer's disease (AD) is a progressive neurodegenerative disorder with both genetic and environmental factors contributing to its pathogenesis. While early-onset AD has well-established genetic determinants, the genetic basis for late-onset AD remains less clear. This study investigates a large Italian family with late-onset autosomal dominant AD, identifying a novel rare missense variant in <jats:italic>GRIN2C<\/jats:italic> gene associated with the disease, and evaluates the functional impact of this variant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Affected and unaffected members from a Northern Italian family were included. Genomic DNA from family members was extracted and initially screened for pathogenic mutations in <jats:italic>APP<\/jats:italic>, <jats:italic>PSEN1<\/jats:italic>, and <jats:italic>PSEN2<\/jats:italic>, and screened for 77 genes associated with neurodegenerative conditions using NeuroX array assay. Exome sequencing was performed on three affected individuals and two healthy relatives. Bioinformatics analyses were conducted. Functional analysis was performed using primary neuronal cultures, and the impact of the variant was assessed through immunocytochemistry and electrophysiology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Pathogenic variants were not identified in <jats:italic>APP<\/jats:italic>, <jats:italic>PSEN1<\/jats:italic>, or <jats:italic>PSEN2<\/jats:italic>, nor in the 77 genes in NeuroX array assay. Exome Sequencing revealed the c.3215C\u2009&gt;\u2009T p.(A1072V) variant in <jats:italic>GRIN2C<\/jats:italic> gene (NM 000835.6), encoding for the glutamate ionotropic receptor N-methyl-D-aspartate receptor (NMDA) type subunit 2C (GluN2C). This variant segregated in 6 available AD patients in the family and was absent in 9 healthy relatives. Primary rat hippocampal neurons overexpressing GluN2C<jats:sup>A1072V<\/jats:sup> showed an increase in NMDAR-induced currents, suggesting altered glutamatergic transmission. Surface expression assays demonstrated an elevated surface\/total ratio of the mutant GluN2C, correlating with the increased NMDAR current. Additionally, immunocytochemistry revealed in neurons expressing the mutant variant a reduced colocalization between the GluN2C subunit and 14-3-3 proteins, which are known to facilitate membrane trafficking of NMDARs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>We identified a rare missense variant in <jats:italic>GRIN2C<\/jats:italic> associated with late-onset autosomal dominant Alzheimer's disease. These findings highlight the role of GluN2C-containing NMDARs in glutamatergic signaling and their potential contribution to AD pathogenesis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-024-01661-y","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T08:30:11Z","timestamp":1736843411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Elisa","family":"Rubino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Italia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Dimartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Pippucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Roveta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Maria","family":"Cambria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marcinn\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Gallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Rogaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Brusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Gardoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocenzo","family":"Rainero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"6","key":"1661_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneurol.2017.63","volume":"13","author":"YT Wu","year":"2017","unstructured":"Wu YT, Beiser AS, Breteler MMB, et al. The changing prevalence and incidence of dementia over time - current evidence. Nat Rev Neurol. 2017;13(6):327\u201339. https:\/\/doi.org\/10.1038\/nrneurol.2017.63.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1661_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.134393","volume":"25","author":"CA Lan","year":"2018","unstructured":"Lan CA, Hardy J, Schott JM. Alzheimer\u2019s disease. Eur J Neurol. 2018;25(1):59\u201370. https:\/\/doi.org\/10.1111\/ene.134393.","journal-title":"Eur J Neurol"},{"issue":"12","key":"1661_CR3","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","volume":"288","author":"CG Lyketsos","year":"2002","unstructured":"Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment Results From the Cardiovascular Health Study. JAMA. 2002;288(12):1475\u201383. https:\/\/doi.org\/10.1001\/jama.288.12.1475.","journal-title":"JAMA"},{"issue":"2","key":"1661_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.1685","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168\u201374. https:\/\/doi.org\/10.1001\/archpsyc.63.2.1685.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"1661_CR5","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"HM Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e HM, Nicolas G, Wallon D, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PLoS Med. 2017;14(3):e1002270. https:\/\/doi.org\/10.1371\/journal.pmed.1002270.","journal-title":"PLoS Med."},{"issue":"4","key":"1661_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"issue":"9","key":"1661_CR7","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z8","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53(9):1276\u201382. https:\/\/doi.org\/10.1038\/s41588-021-00921-z8.","journal-title":"Nat Genet"},{"issue":"3","key":"1661_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol. 2011;10(3):241\u201352. https:\/\/doi.org\/10.1016\/S1474-4422(10)70325-2.","journal-title":"Lancet Neurol"},{"issue":"Pt 12","key":"1661_CR9","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1093\/brain\/awv268","volume":"138","author":"V Escott-Price","year":"2015","unstructured":"Escott-Price V, Sims R, Bannister C, et al. Common polygenic variation enhances risk prediction for Alzheimer\u2019s disease. Brain. 2015;138(Pt 12):3673\u201384. https:\/\/doi.org\/10.1093\/brain\/awv268.","journal-title":"Brain"},{"issue":"3","key":"1661_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-511","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat Neurosci. 2020;23(3):311\u201322. https:\/\/doi.org\/10.1038\/s41593-020-0599-511.","journal-title":"Nat Neurosci"},{"issue":"4","key":"1661_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1041\u20138. https:\/\/doi.org\/10.3233\/JAD-160763.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1661_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1566524015666150330142807","volume":"15","author":"H Yamamoto","year":"2015","unstructured":"Yamamoto H, Hagino Y, Kasai S, Ikeda K. Specific Roles of NMDA Receptor Subunits in Mental Disorders. Curr Mol Med. 2015;15(3):193\u2013205. https:\/\/doi.org\/10.2174\/1566524015666150330142807.","journal-title":"Curr Mol Med"},{"issue":"1","key":"1661_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11064-018-2634-4","volume":"44","author":"A Kumar","year":"2019","unstructured":"Kumar A, Foster TC. Alteration in NMDA receptor mediated glutamatergic neurotransmission in the hippocampus during senescence. Neurochem Res. 2019;44(1):38\u201348. https:\/\/doi.org\/10.1007\/s11064-018-2634-4.","journal-title":"Neurochem Res"},{"issue":"1","key":"1661_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kalani A, Rai S, et al. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer\u2019s Disease: Understanding the Therapeutics Strategies. Mol Neurobiol. 2016;53(1):648\u201361. https:\/\/doi.org\/10.1007\/s12035-014-9053-6.","journal-title":"Mol Neurobiol"},{"issue":"20","key":"1661_CR15","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.3390\/ijms21207452","volume":"21","author":"VN Bukke","year":"2020","unstructured":"Bukke VN, Archana M, Villani R, et al. The Dual Role of Glutamatergic Neurotransmission in Alzheimer\u2019s Disease: From Pathophysiology to Pharmacotherapy. Int J Mol Sci. 2020;21(20):7452. https:\/\/doi.org\/10.3390\/ijms21207452.","journal-title":"Int J Mol Sci"},{"key":"1661_CR16","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FG De Felice","year":"2007","unstructured":"De Felice FG, Velasco PT, Lambert MP, et al. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem. 2007;282:11590\u2013601. https:\/\/doi.org\/10.1074\/jbc.M607483200.","journal-title":"J Biol Chem"},{"key":"1661_CR17","doi-asserted-by":"publisher","first-page":"929474","DOI":"10.3389\/fragi.2022.929474","volume":"3","author":"MF Cox","year":"2022","unstructured":"Cox MF, Hascup ER, Bartke A, Hascup KN. Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer\u2019s Disease. Front Aging. 2022;3:929474. https:\/\/doi.org\/10.3389\/fragi.2022.929474.","journal-title":"Front Aging."},{"key":"1661_CR18","doi-asserted-by":"publisher","first-page":"8407609","DOI":"10.1155\/2018\/8407609","volume":"2018","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhou Y. 14-3-3 Proteins in Glutamatergic Synapses. Neural Plast. 2018;2018:8407609. https:\/\/doi.org\/10.1155\/2018\/8407609.","journal-title":"Neural Plast"},{"issue":"7","key":"1661_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman DA, Folstein M, Katzman R, Price DL, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease\u2014report of the NINCDS\u2013ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology. 1984;34(7):939\u201344. https:\/\/doi.org\/10.1212\/wnl.34.7.939.","journal-title":"Neurology"},{"issue":"4","key":"1661_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jr Jack","year":"2018","unstructured":"Jr Jack CR, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1661_CR21","doi-asserted-by":"publisher","first-page":"545.e9","DOI":"10.1016\/j.neurobiolaging.2014.07.038","volume":"36","author":"M Ghani","year":"2015","unstructured":"Ghani M, Lang AE, Zinman L, et al. Mutation analysis of patients with neurodegenerative disorders using NeuroX array. Neurobiol Aging. 2015;36(1):545.e9-14. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.038.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1661_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589\u201395. https:\/\/doi.org\/10.1093\/bioinformatics\/btp698.","journal-title":"Bioinformatics"},{"issue":"5","key":"1661_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491\u20138. https:\/\/doi.org\/10.1038\/ng.806.","journal-title":"Nat Genet"},{"issue":"16","key":"1661_CR24","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","journal-title":"Bioinformatics"},{"issue":"1","key":"1661_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17(1):122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4.","journal-title":"Genome Biol"},{"key":"1661_CR26","doi-asserted-by":"publisher","unstructured":"MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains Human Mutation. 2019;1\u20139. https:\/\/doi.org\/10.1002\/humu.23798.","DOI":"10.1002\/humu.23798"},{"issue":"2","key":"1661_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1534\/genetics.113.150029","volume":"194","author":"BL Browning","year":"2013","unstructured":"Browning BL, Browning SR. Improving the accuracy and efficiency of identity-by-descent detection in population data. Genetics. 2013;194(2):459\u201371. https:\/\/doi.org\/10.1534\/genetics.113.150029.","journal-title":"Genetics"},{"issue":"1","key":"1661_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng786","volume":"30","author":"GR Abecasis","year":"2002","unstructured":"Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin\u2013rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002;30(1):97\u2013101. https:\/\/doi.org\/10.1038\/ng786.","journal-title":"Nat Genet"},{"key":"1661_CR29","unstructured":"The genome Aggregation Database (gnomAD) https:\/\/gnomad.broadinstitute.org\/news\/2017-02-the-genome-aggregation-database\/22. The genome Aggregation Database (gnomAD) https:\/\/gnomad.broadinstitute.org\/news\/2017-02-the-genome-aggregation-database\/."},{"issue":"5","key":"1661_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"D1","key":"1661_CR31","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1014","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886\u201394. https:\/\/doi.org\/10.1093\/nar\/gky1014.","journal-title":"Nucleic Acids Res"},{"key":"1661_CR32","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.3791\/3634","volume":"65","author":"ML Seibenhener","year":"2012","unstructured":"Seibenhener ML, Wooten MW. Isolation and Culture of Hippocampal Neurons from Prenatal Mice. J Vis Exp. 2012;65:3634. https:\/\/doi.org\/10.3791\/3634.","journal-title":"J Vis Exp"},{"issue":"10","key":"1661_CR33","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1093\/cercor\/bhw125","volume":"26","author":"L Pizzamiglio","year":"2016","unstructured":"Pizzamiglio L, Focchi E, Murru L, et al. New Role of ATM in Controlling GABAergic Tone During Development. Cereb Cortex. 2016;26(10):3879\u201388. https:\/\/doi.org\/10.1093\/cercor\/bhw125.","journal-title":"Cereb Cortex"},{"issue":"3","key":"1661_CR34","doi-asserted-by":"publisher","first-page":"e133654","DOI":"10.1172\/jci.insight.133654","volume":"6","author":"L Pizzamiglio","year":"2021","unstructured":"Pizzamiglio L, Focchi E, Cambria C, et al. The DNA repair protein ATM as a target in autism spectrum disorder. JCI Insight. 2021;6(3): e133654. https:\/\/doi.org\/10.1172\/jci.insight.133654.","journal-title":"JCI Insight"},{"issue":"6","key":"1661_CR35","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/npp.2011.12","volume":"36","author":"D Xi","year":"2011","unstructured":"Xi D, Li YC, Snyder MA, et al. Group II Metabotropic Glutamate Receptor Agonist Ameliorates MK801-Induced Dysfunction of NMDA Receptors via the Akt\/GSK-3\u03b2 Pathway in Adult Rat Prefrontal Cortex. Neuropsychopharmacol. 2011;36(6):1260\u201374. https:\/\/doi.org\/10.1038\/npp.2011.12.","journal-title":"Neuropsychopharmacol"},{"issue":"12","key":"1661_CR36","doi-asserted-by":"publisher","first-page":"e0261791","DOI":"10.1371\/journal.pone.0261791","volume":"16","author":"GS Lee","year":"2021","unstructured":"Lee GS, Zhang J, Wu Y, Zhou Y. 14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons. PLoS ONE. 2021;16(12):e0261791. https:\/\/doi.org\/10.1371\/journal.pone.0261791.","journal-title":"PLoS ONE."},{"key":"1661_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/B978-0-444-64076-5.00026-0","volume":"148","author":"S Carmona","year":"2018","unstructured":"Carmona S, Hardy J, Guerreiro R. The genetic landscape of Alzheimer disease. Handb Clin Neurol. 2018;148:395\u2013408. https:\/\/doi.org\/10.1016\/B978-0-444-64076-5.00026-0.","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"1661_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0358-2.","journal-title":"Nat Genet"},{"issue":"1","key":"1661_CR39","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","volume":"12","author":"I de Rojas","year":"2021","unstructured":"de Rojas I, Moreno-Grau S, Tesi N, et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat Commun. 2021;12(1):3417. https:\/\/doi.org\/10.1038\/s41467-021-22491-8.","journal-title":"Nat Commun"},{"issue":"12","key":"1661_CR40","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","volume":"54","author":"H Holstege","year":"2022","unstructured":"Holstege H, Hulsman M, Charbonnier C, et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer\u2019s disease. Nat Genet. 2022;54(12):1786\u201394. https:\/\/doi.org\/10.1038\/s41588-022-01208-7.","journal-title":"Nat Genet"},{"key":"1661_CR41","doi-asserted-by":"publisher","first-page":"38321","DOI":"10.1038\/srep38321","volume":"6","author":"SC Gupta","year":"2016","unstructured":"Gupta SC, Ravikrishnan A, Liu J, et al. The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function. Sci Rep. 2016;6:38321. https:\/\/doi.org\/10.1038\/srep38321.","journal-title":"Sci Rep"},{"issue":"1","key":"1661_CR42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbrc.2017.10.171","volume":"495","author":"A Holmes","year":"2018","unstructured":"Holmes A, Zhou N, Donahue DL, Balsara R, Castellino FJ. A deficiency of the GluN2C subunit of the N-methyl-D-aspartate receptor is neuroprotective in a mouse model of ischemic stroke. Biochem Biophys Res Commun. 2018;495(1):136\u201344. https:\/\/doi.org\/10.1016\/j.bbrc.2017.10.171.","journal-title":"Biochem Biophys Res Commun"},{"key":"1661_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s10517-023-05882-3","volume":"175","author":"CI Arkhipov","year":"2023","unstructured":"Arkhipov CI, Chernomorets IY, Zhuikova NS, et al. The Role of NMDA Receptor Subunits in the Effect of Memantine on the Brain of Healthy Animals. Bull Exp Biol Med. 2023;175:446\u20139. https:\/\/doi.org\/10.1007\/s10517-023-05882-3.","journal-title":"Bull Exp Biol Med"},{"issue":"2","key":"1661_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","volume":"167","author":"W Danysz","year":"2012","unstructured":"Danysz W, Parsons CG. Alzheimer\u2019s disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections. Br J Pharmacol. 2012;167(2):324\u201352. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02057.x.","journal-title":"Br J Pharmacol"},{"key":"1661_CR45","doi-asserted-by":"publisher","first-page":"174480691770192","DOI":"10.1177\/1744806917701921","volume":"13","author":"Y Wu","year":"2017","unstructured":"Wu Y, Chen C, Yang Q, Jiao M, Qiu S. Endocytosis of GluN2B-containing NMDA receptor mediates NMDA-induced excitotoxicity. Mol Pain. 2017;13:1744806917701921. https:\/\/doi.org\/10.1177\/1744806917701921.","journal-title":"Mol Pain"},{"key":"1661_CR46","doi-asserted-by":"publisher","unstructured":"Findley CA, Bartke A, Hascup KN, Hascup ER. Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer\u2019s Disease Progression. ASN Neuro. 2019;11. https:\/\/doi.org\/10.1177\/1759091419855541.","DOI":"10.1177\/1759091419855541"},{"issue":"11","key":"1661_CR47","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.3390\/ijms22115900","volume":"22","author":"PP Guan","year":"2021","unstructured":"Guan PP, Cao LL, Wang P. Elevating the Levels of Calcium Ions Exacerbate Alzheimer\u2019s Disease via Inducing the Production and Aggregation of \u03b2-Amyloid Protein and Phosphorylated Tau. Int J Mol Sci. 2021;22(11):5900. https:\/\/doi.org\/10.3390\/ijms22115900.","journal-title":"Int J Mol Sci"},{"key":"1661_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13073-023-01233-z","volume":"15","author":"A Neumann","year":"2023","unstructured":"Neumann A, Ohlei O, K\u00fc\u00e7\u00fckali F, et al. Multivariate GWAS of Alzheimer\u2019s disease CSF biomarker profiles implies GRIN2D in synaptic functioning. Genome Med. 2023;15:79. https:\/\/doi.org\/10.1186\/s13073-023-01233-z.","journal-title":"Genome Med"},{"issue":"6","key":"1661_CR49","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0092-8674(00)81067-3","volume":"84","author":"AJ Muslin","year":"1996","unstructured":"Muslin AJ, Tanner JW, Allen PM, Shaw AS. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell. 1996;84(6):889\u201397. https:\/\/doi.org\/10.1016\/s0092-8674(00)81067-3.","journal-title":"Cell"},{"issue":"24","key":"1661_CR50","doi-asserted-by":"publisher","first-page":"15457","DOI":"10.3390\/ijms232415457","volume":"23","author":"A Ganne","year":"2022","unstructured":"Ganne A, Balasubramaniam M, Mainali N, Atluri P, Shmookler Reis RJ, Ayyadevara S. Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases. Int J Mol Sci. 2022;23(24):15457. https:\/\/doi.org\/10.3390\/ijms232415457.","journal-title":"Int J Mol Sci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01661-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:07:48Z","timestamp":1736885268000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01661-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01661-y","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants provided informed consent and demonstrated comprehension of the study\u2019s objectives and procedures. All experimental protocols adhered to the ethical standards set forth in the Declaration of Helsinki. Ethical approval was obtained from the local Committee of the Citt\u00e0 della Salute e della Scienza di Torino (protocol 0114576).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}